课题基金 / 基金详情

NCI PHYSICIAN-INVESTIGATOR DEVELOPMENT AWARD PROGRAM

NCI PHYSICIAN-INVESTIGATOR DEVELOPMENT AWARD PROGRAM
NCI 医师-研究员发展奖励计划
批准号:
3079607
负责人:
Arnold S. Freedman
金额:
$6.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-08-01 至 1989-07-31

项目摘要

项目成果

Arnold S. Freedman的其他基金

相似基金

相关文献

中文摘要
翻译
该项目的总体目标是对细胞的功能进行表征 活化的但不是静止的人B细胞表面抗原的表达 淋巴细胞。这些抗原是细胞表面极好的候选抗原。 控制B细胞激活、增殖和 差异化。这项建议将涉及对B细胞的详细分析 激活抗原要特别注意:1)刺激 诱导它们的表达,2)它们与其他B细胞抗原的关系 在静息和活化的B细胞上均有表达,3)它们与 与增殖有关的生长和分化因子 B细胞和免疫球蛋白分泌的刺激,以及4) 这些抗原在肿瘤B细胞上的表达及其可能的作用 在肿瘤B细胞增殖中的作用。要做到这一点,单克隆体 已知的和新的B细胞激活抗原的抗体将是 发展起来的,并被广泛描述的。这些抗原的表达 将与B细胞活化/增殖阶段和 区分,更重要的是,将尝试定义 这些抗原在功能上的重要性。最后,B细胞的表达 激活抗原将在B细胞白血病和淋巴瘤上进行检测。 这样做是为了确定是否存在关联 肿瘤B细胞上的抗原表达与两者的能力 在体外对激活/增殖的生理触发反应为 以及临床表现和病程。
英文摘要
The overall aim of this project is the functional characterization of cell surface antigens expressed on activated but not resting human B lymphocytes. These antigens are excellent candidates for cell surface structures which control B cell activation, proliferation, and differentiation. This proposal will involve a detailed analysis of B cell activation antigens with specific attention to: 1) the stimuli which induce their expression, 2) their relationship to other B cell antigens expressed on both resting and activated B cells, 3) their relationship to growth and differentiation factors which are involved in the proliferation of B cells and stimulation of immunoglobulin secretion, and 4) the expression of these antigens on neoplastic B cells, and their possible role in neoplastic B cell proliferation. To accomplish this, monoclonal antibodies to previously known and new B cell activation antigens will be developed, and extensively characterized. The expression of these antigens will be related to the stages of B cell activation/proliferation and differentiation, and more importantly an attempt will be made to define the functional importance of these antigens. Finally, the expression of B cell activation antigens will be examined on B cell leukemias and lymphomas. This will be done in order to determine whether there is a correlation between antigen expression on neoplastic B cells and both the ability to respond to physiologic triggers of activation/proliferation in vitro as well as the clinical presentation and course of disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CpG Plus Rituximab Therapy in Follicular Lymphoma
  • 批准号:
    6792326
  • 项目类别:
  • 资助金额:
    $28.46万
  • 财政年份:
    2004
  • 负责人:
    Arnold S. Freedman
  • 依托单位:
CpG Plus Rituximab Therapy in Follicular Lymphoma
  • 批准号:
    6889316
  • 项目类别:
  • 资助金额:
    $28.27万
  • 财政年份:
    2004
  • 负责人:
    Arnold S. Freedman
  • 依托单位:
Etanercept Therapy in Follicular Lymphoma
  • 批准号:
    6585639
  • 项目类别:
  • 资助金额:
    $28.47万
  • 财政年份:
    2002
  • 负责人:
    Arnold S. Freedman
  • 依托单位:
Etanercept Therapy in Follicular Lymphoma
  • 批准号:
    6660312
  • 项目类别:
  • 资助金额:
    $28.46万
  • 财政年份:
    2002
  • 负责人:
    Arnold S. Freedman
  • 依托单位:
海外基金